“…The goal of the present study is to incorporate the hypothesized qualitative and quantitative effects of Abeta on neuronal population dynamics into our brain network models, i.e., adding mathematical models that describe how molecular changes alter population activity—so called cause-and-effect models. We will focus here on the disrupted inhibitory function of interneurons and consecutive hyperexcitability caused by Abeta—while we are aware of various other factors with potential roles for AD etiology, such as vascular changes (Love and Miners, 2016; Storck and Pietrzik Claus, 2018; Bannai et al, 2019), neuroinflammation (Heneka et al, 2015a,b; Wang and Colonna, 2019; Zhou et al, 2019), genetics (Mahley, 2016; Hudry et al, 2019; Takatori et al, 2019), environmental factors (Alonso et al, 2018; McLachlan et al, 2019) and concomitant proteinopathies others than Abeta pathology (Robinson et al, 2018a,b). Beside Abeta there is a second molecular hallmark associated with the pathogenesis of AD: the phosphorylated Tau “tubulin-associated unit” protein (Bloom, 2014; Guo et al, 2017; Tapia-Rojas et al, 2019) which contributes to microtubule stability in the neural cytoskeleton (Guo et al, 2017).…”